Association of chromosome 19 to lung cancer genotypes and phenotypes

Combining AKT inhibition with chloroquine and gefitinib prevents compensatory autophagy and induces cell death in EGFR mutated NSCLC cells

(2015) Sivan M. Bokobza et al.   Oncotarget

BRG1/SMARCA4 Inactivation Promotes Non-Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization

(2014) T. Orvis et al.   CANCER RESEARCH

Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins

(2014) Cheryl F. Lichti et al.   JOURNAL OF PROTEOME RESEARCH

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis

(2014) Shigeki Umemura et al.   Journal of Thoracic Oncology

FOXM1 Regulated by ERK Pathway MediatesTGF-β1-Induced EMT in NSCLC

(2014) Fei-Fei Kong et al.   ONCOLOGY RESEARCH

Smoking Dysregulates the Human Airway Basal Cell Transcriptome at COPD Risk Locus 19q13.2

(2014) Dorothy M. Ryan et al.   PLoS One

Polymorphism in PHD1 gene and risk of non-small cell lung cancer in a Chinese population

(2014) Jianhua Che et al.   TUMOR BIOLOGY

Over-expression of prolyl hydroxylase-1 blocks NF-κB-mediated cyclin D1 expression and proliferation in lung carcinoma cells

(2014) Xiao Xie et al.   Cancer Genetics

Mirk/Dyrk1B mediates G0/G1 to S phase cell cycle progression and cell survival involving MAPK/ERK signaling in human cancer cells

(2013) Jingchun Gao et al.   Cancer Cell International

HapMap-based study identifies risk sub-region on chromosome 19q13.3 in relation to lung cancer among Chinese

(2013) Jiaoyang Yin et al.   Cancer Epidemiology

19q13-ERCC1 Gene Copy Number Increase in Non–Small-Cell Lung Cancer

(2013) Elsa Vanhecke et al.   Clinical Lung Cancer

Effects of PPP1R13L and CD3EAP variants on lung cancer susceptibility among nonsmoking Chinese women

(2013) Jiaoyang Yin et al.   GENE

Variants in two adjacent genes, EGLN2 and CYP2A6, influence smoking behavior related to disease risk via different mechanisms

(2013) A. J. Bloom et al.   HUMAN MOLECULAR GENETICS

Integrated Chromosome 19 Transcriptomic and Proteomic Data Sets Derived from Glioma Cancer Stem-Cell Lines

(2013) Cheryl F. Lichti et al.   JOURNAL OF PROTEOME RESEARCH

Phospho Switch Triggers Brd4 Chromatin Binding and Activator Recruitment for Gene-Specific Targeting

(2013) Shwu-Yuan Wu et al.   MOLECULAR CELL

Brd4 maintains constitutively active NF-κB in cancer cells by binding to acetylated RelA

(2013) Z Zou et al.   ONCOGENE

Molecular alterations in AKT and its protein activation in human lung carcinomas

(2012) Yoh Dobashi et al.   HUMAN PATHOLOGY

Chromosome 19 Annotations with Disease Speciation: A First Report from the Global Research Consortium

(2012) Carol L. Nilsson et al.   JOURNAL OF PROTEOME RESEARCH

The Proteome Browser Web Portal

(2012) Robert J. A. Goode et al.   JOURNAL OF PROTEOME RESEARCH

Accumulation of genomic alterations in 2p16, 9q33.1 and 19p13 in lung tumours of asbestos-exposed patients

(2012) Penny Nymark et al.   Molecular Oncology

The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome

(2012) Young-Ki Paik et al.   NATURE BIOTECHNOLOGY

Novel BRD4–NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma

(2012) K Thompson-Wicking et al.   ONCOGENE

Genetic Polymorphisms in 15q25 and 19q13 Loci, Cotinine Levels, and Risk of Lung Cancer in EPIC

(2011) M. N. Timofeeva et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Genomic Profiles Specific to Patient Ethnicity in Lung Adenocarcinoma

(2011) P. Broet et al.   CLINICAL CANCER RESEARCH

The role of LKB1 in lung cancer

(2011) Montse Sanchez-Cespedes   Familial Cancer

Antibody-based Protein Profiling of the Human Chromosome 21

(2011) Mathias Uhlén et al.   MOLECULAR & CELLULAR PROTEOMICS

The Human Proteome Project: Current State and Future Direction

(2011) Pierre Legrain et al.   MOLECULAR & CELLULAR PROTEOMICS

Frequent homozygous deletion of the LKB1/STK11 gene in non-small cell lung cancer

(2011) R K Gill et al.   ONCOGENE

Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells

(2010) Jingchun Gao et al.   CANCER BIOLOGY & THERAPY

Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma

(2010) Giuseppe Bronte et al.   CANCER TREATMENT REVIEWS

Proteomics, Human Proteome Project, and Chromosomes

(2010) William Hancock et al.   JOURNAL OF PROTEOME RESEARCH

Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients

(2010) Giovanna E. Carpagnano et al.   LUNG CANCER

A Gene-centric Human Proteome Project

(2010)   MOLECULAR & CELLULAR PROTEOMICS

Regulation of Chromatin Architecture by the PWWP Domain-Containing DNA Damage-Responsive Factor EXPAND1/MUM1

(2010) Michael S.Y. Huen et al.   MOLECULAR CELL

LKB1 and AMP-activated protein kinase control of mTOR signalling and growth

(2009) R. J. Shaw   Acta Physiologica

BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer

(2009) S. Rodriguez-Nieto et al.   CARCINOGENESIS

Genomic aberrations in squamous cell lung carcinoma related to lymph node or distant metastasis

(2009) Mirjam C. Boelens et al.   LUNG CANCER

Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization

(2008) Hua Shen et al.   CANCER GENETICS AND CYTOGENETICS

Aberrations of chromosome 19 in asbestos-associated lung cancer and in asbestos-induced micronuclei of bronchial epithelial cells in vitro

(2008) Salla T. Ruosaari et al.   CARCINOGENESIS

Haplotypes of nine single nucleotide polymorphisms on chromosome 19q13.2-3 associated with susceptibility of lung cancer in a Chinese population

(2008) Jiaoyang Yin et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS